Resmed (RMD) Other financing activities (2009 - 2021)

Resmed (RMD) has 13 years of Other financing activities data on file, last reported at $16.1 million in Q4 2021.

• For the quarter ending Q4 2021, Other financing activities rose 4.76% year-over-year to $16.1 million; the trailing twelve-month figure through Dec 2021 stood at $48.7 million (down 67.02% YoY), and the FY2021 full-year result was -$50.2 million, down 187.93% from the prior year.
• Other financing activities for Q4 2021 stood at $16.1 million, down from $17.3 million in the prior quarter.
• Across five years, Other financing activities topped out at $102.2 million in Q2 2020 and bottomed at -$914000.0 in Q2 2018.
• The 5-year median for Other financing activities is $13.0 million (2019), against an average of $16.5 million.
• The widest annual swing landed in 2020, when Other financing activities surged 45727.68%; it then sank 100.27% in 2021.
• A 5-year view of Other financing activities shows it stood at $12.0 million in 2017, then climbed by 4.53% to $12.5 million in 2018, then climbed by 12.09% to $14.1 million in 2019, then grew by 9.34% to $15.4 million in 2020, then gained by 4.76% to $16.1 million in 2021.
• The last three Other financing activities figures came in at $16.1 million (Q4 2021), $17.3 million (Q3 2021), and -$271000.0 (Q2 2021), per Business Quant data.

Peer Comparison